News

Wedgewood Pharmacy is compounding Tiny Tabs in Megestrol Acetate 5mg and Famciclovir 31.25mg, in response to requests from veterinarians. Megestrol Acetate is commonly prescribed by veterinarians for behavioral-

Theravance has received a complete response letter from the FDA related to the telavancin New Drug Application (NDA) for the treatment of nosocomial pneumonia (NP). Telavancin is a

Ambrilia Biopharma has extended the license option agreement with ZBx that granted ZBx the worldwide rights to develop, manufacture and commercialise Ambrilia’s PSP94 technology in ZBx’s zap rapid

Lupin has reported that the FDA has started the inspection of its plant in Indore. After the company receives the approval from FDA, it is expected to initiate

Eli Lilly has received FDA approval for Cymbalta (duloxetine HCl) for the maintenance treatment of generalised anxiety disorder (GAD) in adults, The efficacy and safety of Cymbalta for

Lundbeck has initiated a multi-centre, placebo-controlled, fixeddose study of Lu AE58054 as add-on to donepezil in patients with moderate alzheimer’s disease. The clinical Phase II study is planned

BioMarin has announced that the FDA has granted orphan drug designation for 3,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP has previously received

Allos has reported that the US Patent and Trademark Office (USPTO) has issued a patent for the use of Folotyn (pralatrexate injection) for the treatment of T-cell lymphoma.

Suven Life Sciences has secured three patents EP1537113, EP1704154 and EP1856132 issued by European Patent Office (EPO).These patents corresponds to three New Chemical Entities (NCEs) for the treatment